Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Excellent

<< Previous

Bullboard Posts

Next >>

Comment by houbahopon Jan 12, 2021 3:52pm

109 Views

Post# 32278376

RE:RE:RE:Excellent

Like I wrote over and over, there is no money to be made for long term investors in this company.
Theratechnologies management will always outmaneuver shareholders to prioritize their high salaries. The only way to make money in this stock is to trade it. Absolutely do not stay long in this stock.
Management has a long history (over 20 years!!!) of opacity in order to create oportunities for a few friends. Shareholders hold the bag at the end.

<< Previous

Bullboard Posts

Next >>

Barrick Gold employees detained in Mali amid ongoing dispute